In exchange, MC2 Therapeutics is eligible to receive upfront to launch payments of
Wynzora Cream (50 -microg/g calcipotriol and 0.5 mg/g betamethasone as dipropionate) received
(C) 2021 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.555 EUR | +4.31% | +10.88% | +14.30% |
11:41am | Almirall: share price rises after 'solid' start to the year | CF |
10:37am | European shares listless as investors brace for inflation test | RE |
In exchange, MC2 Therapeutics is eligible to receive upfront to launch payments of
Wynzora Cream (50 -microg/g calcipotriol and 0.5 mg/g betamethasone as dipropionate) received
(C) 2021 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+14.12% | 2.07B | |
+30.38% | 684B | |
+29.44% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.34% | 240B | |
+9.46% | 208B | |
-7.36% | 200B | |
+7.68% | 166B |